168 related articles for article (PubMed ID: 26851005)
1. Surgical and Oncological Factors Affecting the Successful Engraftment of Patient-derived Xenografts in Pancreatic Ductal Adenocarcinoma.
Jun E; Jung J; Jeong SY; Choi EK; Kim MB; Lee JS; Hong SM; Seol HS; Hwang C; Hoffman RM; Shim IK; Chang S; Kim SC
Anticancer Res; 2016 Feb; 36(2):517-21. PubMed ID: 26851005
[TBL] [Abstract][Full Text] [Related]
2. The canary in the coal mine: the growth of patient-derived tumorgrafts in mice predicts clinical recurrence after surgical resection of pancreatic ductal adenocarcinoma.
Thomas RM; Truty MJ; Kim M; Kang Y; Zhang R; Chatterjee D; Katz MH; Fleming JB
Ann Surg Oncol; 2015; 22(6):1884-92. PubMed ID: 25404477
[TBL] [Abstract][Full Text] [Related]
3. Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival.
Pergolini I; Morales-Oyarvide V; Mino-Kenudson M; Honselmann KC; Rosenbaum MW; Nahar S; Kem M; Ferrone CR; Lillemoe KD; Bardeesy N; Ryan DP; Thayer SP; Warshaw AL; Fernández-Del Castillo C; Liss AS
PLoS One; 2017; 12(8):e0182855. PubMed ID: 28854237
[TBL] [Abstract][Full Text] [Related]
4. Oncological and genetic factors impacting PDX model construction with NSG mice in pancreatic cancer.
Guo S; Gao S; Liu R; Shen J; Shi X; Bai S; Wang H; Zheng K; Shao Z; Liang C; Peng S; Jin G
FASEB J; 2019 Jan; 33(1):873-884. PubMed ID: 30091943
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a Liver Transplant Patient-derived Tumor Xenograft (PDX) Model Using Cryopreserved Pancreatic Ductal Adenocarcinoma.
Tanaka R; Kageyama K; Kimura K; Eguchi S; Tauchi J; Shinkawa H; Ohira GO; Yamazoe S; Yamamoto A; Tanaka S; Amano R; Tanaka H; Yashiro M; Kubo S; Ohira M
Anticancer Res; 2020 May; 40(5):2637-2644. PubMed ID: 32366408
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma.
Nitori N; Ino Y; Nakanishi Y; Yamada T; Honda K; Yanagihara K; Kosuge T; Kanai Y; Kitajima M; Hirohashi S
Clin Cancer Res; 2005 Apr; 11(7):2531-9. PubMed ID: 15814630
[TBL] [Abstract][Full Text] [Related]
7. Establishment of Patient-derived Orthotopic Xenografts (PDX) as Models for Pancreatic Ductal Adenocarcinoma.
Magouliotis DE; Lafazanis K; Koutsougianni F; Sakellaridis N; Ioannou M; Zacharoulis D; Dimas K
In Vivo; 2022; 36(3):1114-1119. PubMed ID: 35478141
[TBL] [Abstract][Full Text] [Related]
8. Decreased TIP30 expression predicts poor prognosis in pancreatic cancer patients.
Guo S; Jing W; Hu X; Zhou X; Liu L; Zhu M; Yin F; Chen R; Zhao J; Guo Y
Int J Cancer; 2014 Mar; 134(6):1369-78. PubMed ID: 24037692
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Tbx3 predicts poor prognosis of patients with resectable pancreatic carcinoma.
Wang HC; Meng QC; Shan ZZ; Yuan Z; Huang XY
Asian Pac J Cancer Prev; 2015; 16(4):1397-401. PubMed ID: 25743805
[TBL] [Abstract][Full Text] [Related]
10. Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis.
La Torre M; Cavallini M; Ramacciato G; Cosenza G; Rossi Del Monte S; Nigri G; Ferri M; Mercantini P; Ziparo V
J Surg Oncol; 2011 Nov; 104(6):629-33. PubMed ID: 21713779
[TBL] [Abstract][Full Text] [Related]
11. Clinical, molecular and genetic validation of a murine orthotopic xenograft model of pancreatic adenocarcinoma using fresh human specimens.
Walters DM; Stokes JB; Adair SJ; Stelow EB; Borgman CA; Lowrey BT; Xin W; Blais EM; Lee JK; Papin JA; Parsons JT; Bauer TW
PLoS One; 2013; 8(10):e77065. PubMed ID: 24204737
[TBL] [Abstract][Full Text] [Related]
12. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
[TBL] [Abstract][Full Text] [Related]
13. Expression of the Novel Costimulatory Molecule B7-H5 in Pancreatic Cancer.
Byers JT; Paniccia A; Kaplan J; Koenig M; Kahn N; Wilson L; Chen L; Schulick RD; Edil BH; Zhu Y
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1574-9. PubMed ID: 25519928
[TBL] [Abstract][Full Text] [Related]
14. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
[TBL] [Abstract][Full Text] [Related]
15. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
[TBL] [Abstract][Full Text] [Related]
16. Clinical Implications of NRAS Overexpression in Resectable Pancreatic Adenocarcinoma Patients.
Martinez-Useros J; Li W; Georgiev-Hristov T; Fernandez-Aceñero MJ; Borrero-Palacios A; Perez N; Celdran A; Garcia-Foncillas J
Pathol Oncol Res; 2019 Jan; 25(1):269-278. PubMed ID: 29101736
[TBL] [Abstract][Full Text] [Related]
17. Patient-derived xenograft model engraftment predicts poor prognosis after surgery in patients with pancreatic cancer.
Chen Q; Wei T; Wang J; Zhang Q; Li J; Zhang J; Ni L; Wang Y; Bai X; Liang T
Pancreatology; 2020 Apr; 20(3):485-492. PubMed ID: 32113935
[TBL] [Abstract][Full Text] [Related]
18. Usp9x Promotes Survival in Human Pancreatic Cancer and Its Inhibition Suppresses Pancreatic Ductal Adenocarcinoma In Vivo Tumor Growth.
Pal A; Dziubinski M; Di Magliano MP; Simeone DM; Owens S; Thomas D; Peterson L; Potu H; Talpaz M; Donato NJ
Neoplasia; 2018 Feb; 20(2):152-164. PubMed ID: 29248719
[TBL] [Abstract][Full Text] [Related]
19. Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice.
Chen Y; Zhang R; Wang L; Correa AM; Pataer A; Xu Y; Zhang X; Ren C; Wu S; Meng QH; Fujimoto J; Jensen VB; Antonoff MB; Hofstetter WL; Mehran RJ; Pisimisis G; Rice DC; Sepesi B; Vaporciyan AA; Walsh GL; Swisher SG; Roth JA; Heymach JV; Fang B
Cancer; 2019 Nov; 125(21):3738-3748. PubMed ID: 31287557
[TBL] [Abstract][Full Text] [Related]
20. Low expression of IGFBP7 is associated with poor outcome of pancreatic ductal adenocarcinoma.
An W; Ben QW; Chen HT; Zheng JM; Huang L; Li GX; Li ZS
Ann Surg Oncol; 2012 Nov; 19(12):3971-8. PubMed ID: 22622471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
